XML 77 R69.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings Per Share (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Statements [Line Items] |
Summary of Earnings Per Share |
|  | Consolidated |
| June 30, 2025 A$ |  |  | June 30, 2024 A$ |  |  | June 30, 2023 A$ |
Loss after income tax attributable to the owners of Immutep Limited |  |  | (61,434,165 | ) |  |  | (42,716,625 | ) |  |  | (39,896,348 | )
|  | Number |  |  | Number |  |  | Number |
Weighted average number of ordinary shares used in calculating basic earnings per share (EPS) |  |  | 1,455,818,442 |  |  |  | 1,201,061,930 |  |  |  | 892,399,810 |
Weighted average number of ordinary shares used in calculating diluted earnings per share (EPS) |  |  | 1,455,818,442 |  |  |  | 1,201,061,930 |  |  |  | 892,399,810 |
|  | Cents |  |  | Cents |  |  | Cents |
Basic earnings per share |  |  | (4.22 | ) |  |  | (3.56 | ) |  |  | (4.47 | )
Diluted earnings per share |  |  | (4.22 | ) |  |  | (3.56 | ) |  |  | (4.47 | )
Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following table summarizes the convertible notes, performance rights, listed options and unlisted options that were not included in the calculation of weighted average number of ordinary shares because they are anti-dilutive for the periods presented.
|  | Consolidated |
| June 30, 2025 Number |  |  | June 30, 2024 Number |  |  | June 30, 2023 Number |
Unlisted options* |  |  | 847,600 |  |  |  | 847,600 |  |  |  | 847,600 |
Convertible notes |  |  | 7,432,958 |  |  |  | 7,261,072 |  |  |  | 6,646,432 |
Non-executive director performance rights |  |  | 1,211,112 |  |  |  | 2,161,392 |  |  |  | 1,937,065 |
Performance rights |  |  | 16,237,064 |  |  |  | 13,870,535 |  |  |  | 12,130,033 |
** | This is related to warrant associated with convertible notes, please refer to note 17 for more details.

X
- Definition The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share because they are antidilutive for the period(s) presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2025-01-01 -Paragraph 70 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2025-01-01 -Paragraph 66 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_EarningsPerShareExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | immp_StatementsLineItems
Namespace Prefix: | immp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration